91��ɫ

91��ɫ U receives nearly $10 million from Wellcome to continue the fight against antimicrobial resistance

In a global health environment where funding is increasingly tight, 91��ɫ based Global Strategy Lab (GSL) is launching a four-year strategic plan for its initiative, the AMR Policy Accelerator to drive progress against antimicrobial resistance (AMR). Unveiled today by GSL Director Mathieu JP Poirier and Accelerator Managing Director, Geneviève Boily-Larouche, the plan is supported by $9.6 million (£5 million) from Wellcome – a leading global health philanthropy.

91��ɫ U profs with Global Strategy Lab push ambitious 1–10–100 unifying goals on antimicrobial resistance ahead of crucial UN meeting

Researchers share goals of using a One Health-approach, to save 10 million lives and aim for 100 per cent sustainable access to effective antimicrobials in new policy paper TORONTO, September 18, 2024 – Antimicrobial resistance (AMR) contributes to millions of deaths annually, a problem that only becomes more pressing and will be a focus of […]

The war on antimicrobial "superbugs"...is it a losing battle?

War on bugs can’t be won, 91��ɫ U researchers declare

From a wartime spread of antimicrobial resistant disease in Ukraine, to superbugs in China causing “white lung” pneumonia in children, 2023 brought no shortage of new evidence that antimicrobial resistance (AMR) continues to be a pressing problem globally, and this pattern shows no sign of abating in 2024 unless a radical shift occurs.

Politics of climate change offer lessons for fight against antimicrobial resistance

The emerging pandemic of antimicrobial resistance (AMR) and challenges to addressing it have parallels with climate change, said experts at a recent online panel on AMR Policy Leadership and Innovation, hosted by 91��ɫ’s Global Strategy Lab (GSL), as part of World Antimicrobial Resistance Awareness Week. Similar to climate change, AMR is frequently talked about […]

91��ɫ tackles urgent global health threat of antimicrobial resistance

New policy accelerator aims to bridge science and politics with $8.7 million backing from Wellcome Trust TORONTO, Nov. 22, 2022 – While recent health-care attention remains on the ‘triple threat’ of COVID-19, influenza and respiratory syncytial virus, we cannot overlook the emerging pandemic of antimicrobial resistance — an already critical problem with the potential to become so […]